Antihypertensive medications used in SPRINT
| Medication class | Intensive therapy (%) | Standard therapy (%) |
|---|---|---|
| Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers | 76.7 | 55.2 |
| Thiazide-type diuretics | 54.9 | 33.3 |
| Dihydropyridine calcium channel blockers | 52.8 | 31.3 |
| Beta-blockers | 41.1 | 30.8 |
| Aldosterone antagonists | 8.7 | 4.0 |
| Other potassium-sparing diuretics | 3.1 | 2.5 |
| Nondihydropyridine calcium channel blockers | 4.7 | 4.3 |
| Direct vasodilators | 7.3 | 2.4 |
Information from SPRINT Research Group; Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373:2103-21 16.